Zacks: Analysts Set $18.00 Target Price for Simulations Plus, Inc. (SLP)
Shares of Simulations Plus, Inc. (NASDAQ:SLP) have been assigned an average broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the stock, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy recommendation.
Brokers have set a one year consensus price target of $18.00 for the company and are expecting that the company will post $0.09 EPS for the current quarter, according to Zacks. Zacks has also assigned Simulations Plus an industry rank of 199 out of 265 based on the ratings given to its competitors.
Several equities analysts have recently issued reports on the company. BidaskClub raised Simulations Plus from a “hold” rating to a “buy” rating in a report on Thursday, October 5th. Zacks Investment Research cut Simulations Plus from a “hold” rating to a “sell” rating in a report on Friday, December 22nd.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SLP. The Manufacturers Life Insurance Company raised its holdings in Simulations Plus by 13.8% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 8,923 shares of the technology company’s stock worth $110,000 after purchasing an additional 1,085 shares during the period. Rhumbline Advisers acquired a new position in Simulations Plus in the 2nd quarter worth about $126,000. OxFORD Asset Management LLP acquired a new position in Simulations Plus in the 2nd quarter worth about $126,000. New York State Common Retirement Fund purchased a new stake in Simulations Plus during the 2nd quarter worth approximately $143,000. Finally, Blair William & Co. IL purchased a new stake in Simulations Plus during the 2nd quarter worth approximately $164,000. 33.56% of the stock is owned by institutional investors.
Shares of Simulations Plus (NASDAQ SLP) opened at $15.80 on Thursday. The company has a market capitalization of $270.55, a PE ratio of 47.88 and a beta of -0.76. Simulations Plus has a 52-week low of $9.10 and a 52-week high of $17.45.
Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings data on Tuesday, November 14th. The technology company reported $0.06 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.05 by $0.01. The business had revenue of $6.30 million during the quarter, compared to analysts’ expectations of $5.01 million. Simulations Plus had a return on equity of 23.95% and a net margin of 23.94%. research analysts predict that Simulations Plus will post 0.39 earnings per share for the current year.
WARNING: This article was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another website, it was copied illegally and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.americanbankingnews.com/2018/01/04/zacks-analysts-set-18-00-target-price-for-simulations-plus-inc-slp.html.
About Simulations Plus
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.